Dimension Biotechnologies has been selected in Cohort 8 of the KQ Labs Accelerator run by the Francis Crick Institute.

KQ Labs is a five-month programme that supports early-stage data-driven health companies. During the programme, our team will undergo bespoke business support and gain introductions to industry and pharma leaders. The programme includes a £40k investment into Dimension by KQ Labs.

Being selected to be part of this prestigious programme is further validation of our mission to make assessing microvascular health and disease as easy as a routine blood test. We’re thrilled to be a part of it.